Eir Partners Closes Oversubscribed $496 Million Investment Program II
Eir Partners Closes Oversubscribed $496 Million Investment Program II
Dedicated Investment Program II Will Further Eir Partners' Strategy of Partnering with Companies Across the Healthcare Technology & Technology Enabled Services Marketplace
第二期专项投资计划将进一步推动Eir Partners与医疗保健技术和技术支持服务市场的公司合作的战略
MIAMI, May 21, 2024 /PRNewswire/ -- Eir Partners Capital, LLC ("Eir", "Eir Partners" or the "Firm"), a middle market private equity firm focused on healthcare technology and tech-enabled services, today announced the final closing of Eir Partners Investment Program II with $496 million in capital commitments. Eir previously raised $255 million in capital commitments for its inaugural program, Eir Partners Program I, which closed in 2021 and invested in five platform investments.
迈阿密，2024年5月21日 /PRNewswire/ — 专注于医疗保健技术和技术支持服务的中间市场私募股权公司Eir Partners Capital, LLC（“Eir”、“Eir Partners” 或 “公司”）今天宣布Eir Partners第二投资计划的最终结束，资本承诺为4.96亿美元。Eir此前为其首个计划Eir Partners I计划筹集了2.55亿美元的资本承诺，该计划于2021年结束，投资了五项平台投资。
The oversubscribed program was raised in less than four months and secured commitments from a diversified range of investors including leading financial institutions, insurance companies, family offices, funds-of-funds, endowments and foundations, and seasoned industry executives.
这项超额认购计划在不到四个月的时间内筹集到资金，并获得了包括领先金融机构、保险公司、家族办公室、基金会、捐赠基金和基金会以及经验丰富的行业高管在内的多元化投资者的承诺。
"We are thrilled to receive support from a distinguished group of investors to continue our strategy of partnering with exceptional businesses and teams," said Brett Carlson, Founder & Chief Executive Officer of Eir Partners. "Their commitment will help grow and establish Eir as a leading health-tech investment firm in the market."
Eir Partners创始人兼首席执行官布雷特·卡尔森表示：“我们很高兴得到杰出投资者的支持，以继续我们与卓越企业和团队合作的战略。”“他们的承诺将有助于发展和确立Eir作为市场上领先的健康科技投资公司的地位。”
Eir Partners Investment Program II will continue to invest in disruptive companies that have proven market fit and scale demonstrating outsized organic growth potential coupled with accretive M&A opportunities. Eir seeks to partner with businesses where the firm's operating experience and executive advisor network can make an impact across all aspects of the business including technology, finance, sales, and human capital.
Eir Partners投资计划二期将继续投资具有市场契合度和规模的颠覆性公司，这些公司的有机增长潜力巨大，并有更多的并购机会。Eir寻求与公司的运营经验和执行顾问网络可以对业务的各个方面（包括技术、金融、销售和人力资本）产生影响的企业合作。
Lazard Frères & Co. LLC acted as the exclusive placement advisor, and Kirkland & Ellis LLP served as legal counsel in the formation of Eir Partners Investment Program II.
Lazard Freères & Co.有限责任公司担任独家配售顾问，Kirkland & Ellis LLP在Eir Partners投资计划II的组建中担任法律顾问。
About Eir Partners
关于 Eir Partners
Eir Partners Capital, LLC is a Miami-based private equity company focused exclusively on healthcare technology and tech- enabled services. Eir combines its operational expertise with bottoms up thematic sourcing efforts to accelerate value creation. Since inception, Eir has completed transactions across payer, provider, employer and pharma tech, including leading industry names such as Apixio, Capta, GiftHealth, Helpware, and ReviveHealth. Targeted stages of investment include growth equity through control buyouts and equity check sizes range from $25 - $100 million.
Eir Partners Capital, LLC是一家总部位于迈阿密的私募股权公司，专门从事医疗保健技术和技术支持服务。Eir将其运营专业知识与自下而上的主题采购工作相结合，以加速价值创造。自成立以来，Eir已经完成了跨支付方、提供商、雇主和制药科技公司的交易，包括Apixio、Capta、GiftHealth、Helpware和ReviveHealth等领先的行业公司。目标投资阶段包括通过控制权收购实现的成长型股权，股票支票规模从2500万美元到1亿美元不等。
For more information, please visit the Eir Partners website at or the Eir Partners LinkedIn page at
欲了解更多信息，请访问 Eir Partners 网站或 Eir Partners LinkedIn 页面
Contact
联系我们
Chris Tofalli
Chris Tofalli Public Relations, LLC
914-834-4334
[email protected]
克里斯·托法利
克里斯·托法利公共关系有限责任公司
914-834-4334
[电子邮件保护]
SOURCE Eir Partners
来源 Eir Partners
译文内容由第三方软件翻译。